Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Dopamine, depression and antidepressants.

Eric Dailly1, Franck Chenu, Caroline E Renard

  • 1EA 3256 Neurobiologie de l'anxiété et de la dépression, Faculté de Médecine, BP 53508, 1 rue Gaston Veil, 44035 Nantes Cedex 01, France.

Fundamental & Clinical Pharmacology
|November 19, 2004
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Understanding Psychotic Depression.

Advances in experimental medicine and biology·2026
Same author

A priori optimization of levofloxacin dose regimen based on a population pharmacokinetics model.

The Journal of antimicrobial chemotherapy·2025
Same author

Enhancing addiction care: Benefits of urinary screening with LC-HRMS (liquid chromatography-high resolution mass spectrometry) for psychoactive substances and drugs.

Progress in neuro-psychopharmacology & biological psychiatry·2025
Same author

N-acetylcysteine use in a cocaine-induced liver failure: a case report.

Frontiers in toxicology·2025
Same author

The Diagnosis of Bipolar Disorders: A Major Public Health Issue.

Alpha psychiatry·2025
Same author

Efficacy of an inulin-based treatment on intestinal colonization by multidrug-resistant E. coli: insight into the mechanism of action.

Gut microbes·2024
Same journal

Glucagon-Like Peptide-1 Receptor Agonists in Cocaine Use Disorder: Clinical Observations and Underlying Mechanisms.

Fundamental & clinical pharmacology·2026
Same journal

TAAR1-Associated Trace Amines for Cutaneous Nociceptive Blockade in Rats.

Fundamental & clinical pharmacology·2026
Same journal

Synergistic Cardioprotection of Colchicine and Hyperbaric Oxygen Therapy in a Rat Model of Remote Ischemia-Reperfusion Injury.

Fundamental & clinical pharmacology·2026
Same journal

Probucol Exerts Anticancer Effects on SW480 Human Colorectal Cancer Cells via Modulation of Apoptosis- and Angiogenesis-Related Proteins.

Fundamental & clinical pharmacology·2026
Same journal

Nebivolol Protects the Thoracic and Abdominal Aorta and Their Perivascular Adipose Tissue From the Differential Detrimental Effects of Obesity.

Fundamental & clinical pharmacology·2026
Same journal

Monitoring of Clinics That Use Direct-to-Consumer Advertising for Off-Label Ketamine in the New York Metropolitan Area: A Cross-Sectional Systematic Web Search.

Fundamental & clinical pharmacology·2026
See all related articles

Depression may involve dopamine deficiency in the brain's reward pathway. Antipsychotics, like olanzapine, show antidepressant effects, suggesting a complex role for dopamine in mood disorders.

Area of Science:

  • Neuroscience
  • Psychiatry
  • Pharmacology

Background:

  • The link between depression and dopamine deficiency in the mesolimbic pathway is a long-standing hypothesis.
  • Both animal and human studies suggest the involvement of the dopamine system in depression.

Purpose of the Study:

  • To investigate the complex role of dopamine in depression.
  • To explore the antidepressant effects of dopaminergic agents and antagonists.

Main Methods:

  • Review of experimental studies using animal models of depression.
  • Analysis of human studies investigating dopamine system involvement.
  • Examination of antidepressant effects of dopaminergic receptor agonists and antagonists (e.g., olanzapine).

Main Results:

Related Experiment Videos

  • Dopaminergic receptor agonists show antidepressant effects.
  • Antagonists like olanzapine also exhibit antidepressant effects in treatment-resistant depression.
  • These findings present a paradoxical observation regarding dopamine's role.

Conclusions:

  • The precise role of dopamine in depression requires further investigation.
  • Dopamine system modulation offers potential therapeutic avenues for depression.
  • Paradoxical effects of certain drugs highlight the complexity of dopamine's influence on mood.